Key result
Reduced peak V'O2 was identified as the only independent predictor of mortality in patients with cardiac amyloidosis over a median follow-up of 38 months, during which 70% of patients died.
Cohort (n=27)
No takes yet. Share an insight, caveat, or question.
May aid risk stratification in cardiac amyloidosis; hypothesis-generating and requires prospective validation.
Hein et al. (2018) conducted a cohort in Cardiac amyloidosis (n=27). Peak V'O2 was evaluated on Mortality. Reduced peak V'O2 was identified as the only independent predictor of mortality in patients with cardiac amyloidosis over a median follow-up of 38 months, during which 70% of patients died.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: